Amphinex is a photosensitising agent used in photodynamic therapy for treating superficial cancers.
It has had promising preliminary results in early trials on patients with advanced head and neck cancer Successful completion of the third dose group in the Amphinex study. March 2010 http://www.medicalnewstoday.com/articles/176431.php PCI Biotech Reports Successful Completion Of Second Dose Group In Pivotal Amphinex(R) Trial. Jan 2010 "Inoperable cancers killed by new laser surgery" The Times. UK. 3-April-2010 p15
References